Tumor necrosis factor receptor-associated periodic syndrome mimicking systemic juvenile idiopathic arthritis

Allergology International

Volumn 55, Issue 3, 2006, Pages 337-341

  Manki, Akira ^a   Nishikomori, Ryuta ^b   Nakata Hizume, Mami ^b   Kunitomi, Taiji ^c   Takei, Syuji ^d   Urakami, Tomoko ^a   Morishima, Tsuneo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Japanese Red Cross Okayama Hospital   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

C reactive protein (CRP); International League of Associations for Rheumatology (ILAR) criteria; Juvenile idiopathic arthritis (JIA); Tumor necrosis factor receptor associated periodic syndrome (TRAPS)

Indexed keywords

C REACTIVE PROTEIN; CYCLOSPORIN; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DNA SEQUENCE; FAMILY HISTORY; FEMALE; GENE; GENETIC ANALYSIS; HUMAN; IDIOPATHIC DISEASE; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; MALE; MISSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHOOL CHILD; TNFRSF1A GENE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

EID: 33748923780     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.55.337     Document Type: Article

References (18)

1. McDermott MF, Aksentijevich I, Galon J et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999;97:133-144.
2. Masson C, Simon V, Hoppé E, Insalaco P, Cissé I, Audran M. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment, and place relative to other periodic joint diseases. Joint Bone Spine 2004;71:284-291.
3. Nevala H, Karenko L, Stjernberg S et al. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever. Arthritis Rheum. 2002;46:1061-1066.
4. Aganna E, Hammond L, Hawkins PN et al. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum. 2003;48:2632-2644.
5. Ida H, Kawasaki E, Miyashita F et al. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus. Rheumatology 2004;43:1292-1299.
6. Nowlan ML, Drewe E, Bulsara N et al. Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A. Rheumatology 2006;45:31-37.
7. Saulsbury FT, Wispelwey B. Tumor necrosis factor receptor-associated periodic syndrome in a young adult who had features of periodic fever, aphthous stomatitis, pharyngitis, and adenitis as a child. J. Pediatr. 2005;146:283-285.
8. Petty RE, Southwood TR, Baum J et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban 1997. J. Rheumatol. 1998;25:1991-1994.
9. Yilmaz M, Kendirli SG, Altitas D, Bingöl G, Antmen B. Cytokine levels in serum of patients with juvenile rheumatoid arthritis. Clin. Rheumatol. 2001;20:30-35.
10. Gattorno M, Picco P, Buncompabni A et al. Serum p 55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis. Ann. Rheum. Dis. 1996;55:243-247.
11. Kriegel MA, Huffmeier U, Scherb E et al. Tumor necrosis factor receptor-associated periodic syndrome characterized by a mutation affecting the cleavage site of the receptor: implication for the pathogenesis. Arthritis Rheum. 2003;48:2386-2388.
12. Obici L, Marciano S, Palladini G et al. TNFRSF1A mutations in Italian patients affected by apparently sporadic periodic fever syndrome. In: Gerateau G (ed). Amyloid and Amyloidosis Florida: CRC press, 2004;182-184.
13. Touitou I, Lesage S, McDermott M et al. Infevers: An evolving mutation database for auto-inflammatory syndromes. Hum. Mutat. 2004;24:194-198.
14. Huggins ML, Radford PM, McIntosh RS et al. Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2004;50:2651-2656.
15. Kusuhara K, Nomura A, Nakao F, Hara T. Tumor necrosis factor receptor-associated periodic syndrome with a novel mutation in the TNFRSF1A gene in a Japanese family. Eur. J. Pediatr. 2004;163:30-32.
16. Stojanov S, Lohse P, Lohse P et al. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum. 2004;50:1951-1958.
17. Muzaffer MA, Dayer JM, Feldman BM et al. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis. J. Rheumatol. 2002;29:1071-1078.
18. Mangge H, Kenzian H, Gallist S et al. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum. 1995;38:211-220.